168 related articles for article (PubMed ID: 9692108)
21. Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer : cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support.
Fujita A; Takabatake H; Tagaki S; Sekine K
Chest; 2001 Feb; 119(2):340-3. PubMed ID: 11171707
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Hecker D; Hanske M
Semin Oncol; 1996 Dec; 23(6 Suppl 16):47-50. PubMed ID: 9007121
[TBL] [Abstract][Full Text] [Related]
23. [Intrapleural bleomycin for management of malignant pleural effusions].
Sugita T; Matsunaga K; Kobayashi H; Horikawa S; Suzuki Y; Nishiyama H; Maekawa N; Furuta H; Inui H; Fujimoto H
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1203-7. PubMed ID: 7544964
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Ozols RF
J Clin Oncol; 1995 Aug; 13(8):1860-70. PubMed ID: 7543559
[TBL] [Abstract][Full Text] [Related]
25. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients.
Shimizu T; Takahashi N; Terakado M; Akusawa H; Tsujino I; Horie T
Intern Med; 2006; 45(11):715-20. PubMed ID: 16819251
[TBL] [Abstract][Full Text] [Related]
26. Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis.
Ohta Y; Shimizu Y; Matsumoto I; Watanabe G
J Exp Clin Cancer Res; 2006 Mar; 25(1):15-9. PubMed ID: 16761613
[TBL] [Abstract][Full Text] [Related]
27. Combination use of paclitaxel and avastin enhances treatment effect for the NSCLC patients with malignant pleural effusion.
Qi N; Li F; Li X; Kang H; Zhao H; Du N
Medicine (Baltimore); 2016 Nov; 95(47):e5392. PubMed ID: 27893676
[TBL] [Abstract][Full Text] [Related]
28. Intrapleural administration of recombinant interleukin-2 in non-small cell lung cancer with neoplastic pleural effusion.
Masotti A; Fumagalli L; Morandini GC
Monaldi Arch Chest Dis; 1997 Jun; 52(3):225-8. PubMed ID: 9270246
[TBL] [Abstract][Full Text] [Related]
29. A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A.
Usui K; Sugawara S; Nishitsuji M; Fujita Y; Inoue A; Mouri A; Watanabe H; Sakai H; Kinoshita I; Ohhara Y; Maemondo M; Kagamu H; Hagiwara K; Kobayashi K;
Lung Cancer; 2016 Sep; 99():131-6. PubMed ID: 27565928
[TBL] [Abstract][Full Text] [Related]
30. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
[TBL] [Abstract][Full Text] [Related]
31. Streptokinase for malignant pleural effusions: a randomized controlled study.
Okur E; Baysungur V; Tezel C; Ergene G; Okur HK; Halezeroglu S
Asian Cardiovasc Thorac Ann; 2011 Jun; 19(3-4):238-43. PubMed ID: 21885549
[TBL] [Abstract][Full Text] [Related]
32. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion.
Du N; Li X; Li F; Zhao H; Fan Z; Ma J; Fu Y; Kang H
Oncol Rep; 2013 Jun; 29(6):2332-40. PubMed ID: 23525453
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.
Yasuda K; Igishi T; Kawasaki Y; Yamamoto M; Kato K; Matsumoto S; Kotani M; Sako T; Shigeoka Y; Sugitani A; Histuda Y; Shimizu E
Oncology; 2003; 65(3):224-8. PubMed ID: 14657596
[TBL] [Abstract][Full Text] [Related]
34. [Phase III clinical trial of elemenum emulsion in the management of malignant pleural and peritoneal effusions].
Wang J; Zhang H; Sun Y
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):464-7. PubMed ID: 9387305
[TBL] [Abstract][Full Text] [Related]
35. A phase II study of single-agent docetaxel chemotherapy for non-small cell lung cancer.
Perng RP; Shih JF; Chen YM; Chou KC; Lee YC; Tsai CM
Jpn J Clin Oncol; 2000 Oct; 30(10):429-34. PubMed ID: 11185888
[TBL] [Abstract][Full Text] [Related]
36. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D
Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237
[TBL] [Abstract][Full Text] [Related]
37. Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion.
Kitamura K; Kubota K; Ando M; Takahashi S; Nishijima N; Sugano T; Toyokawa M; Miwa K; Kosaihira S; Noro R; Minegishi Y; Seike M; Yoshimura A; Gemma A
Cancer Chemother Pharmacol; 2013 Feb; 71(2):457-61. PubMed ID: 23178954
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer.
Ceresoli GL; Gregorc V; Cordio S; Bencardino KB; Schipani S; Cozzarini C; Bordonaro R; Villa E
Lung Cancer; 2004 May; 44(2):231-9. PubMed ID: 15084388
[TBL] [Abstract][Full Text] [Related]
40. [Administration of docetaxel in cases of recurrent breast carcinoma with malignant pleural effusion controlled by intrapleural administration of OK-432].
Kikumori T; Hayashi H; Shibata A; Sekiya M; Itoh T; Mase T; Oiwa M; Imai T; Funahashi H
Gan To Kagaku Ryoho; 1999 Nov; 26(13):2091-4. PubMed ID: 10584578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
